About Us

Company Overview

Alpheus Medical, Inc. is a privately held biotechnology company developing an investigational therapy that pairs a tumor-accumulating drug with low-intensity ultrasound to achieve localized pharmacologic activation inside solid tumors. This non-invasive, drug-centered approach is intended to activate the molecule directly within tumor cells while minimizing systemic exposure.

The company’s lead program targets glioblastoma and is being evaluated in clinical studies under applicable regulatory oversight.

Leadership

Management Team

Imran Eba


Chief Financial Officer

Jeremy Ling

Chief Technology Officer

Ann-Marie Hulstine


Vice President, Clinical Operations

Mike Preigh, Ph.D

Vice President, Chemistry, Manufacturing & Controls (CMC)

Nick Ellens, Ph.D

Vice President, Research & Development

Board of Directors

Juan-Pablo Mas

Action Potential Venture Capital

Robert Stein, MD

Samsara BioCapital

Peter Thomson, MD

OrbiMed Advisors

Conrad Wang, MD

HealthQuest Capital

Scientific Advisory Board

Roger Stupp, MD

Chief of Neuro-oncology, Professor of Neurological Surgery, Medicine and Neurology, Feinberg School of Medicine at Northwestern University.

David Reardon, MD

Professor, Medicine, Harvard Medical School;
Clinical Director, Center for Neuro-Oncology, Medical Oncology, Dana-Farber Cancer Institute.

Investors